{"database": "openregs", "table": "documents", "rows": [["FDA-2015-N-3326-0038", "FDA", "FDA-2015-N-3326", "Reauthorization of the Biosimilar User Fee Act; Public Meeting; Request for Comments", "Notice", "Request for Comments", "2021-09-22T04:00:00Z", 2021, 9, "2021-09-22T04:00:00Z", "2021-12-03T04:59:59Z", "2021-12-04T02:00:40Z", "2021-20432", 0, 0, "0900006484d9bb68"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2015-N-3326-0038"], "units": {}, "query_ms": 0.44671306386590004, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}